Source: Eur Respir J 2008; 31: 869-873
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Vestbo J., Anderson W., Coxson H. O., Crim C., Dawber F., Edwards L., Hagan G., Knobil K., Lomas D. A., MacNee W., Silverman E. K., Tal-Singer R., on behalf of the ECLIPSE investigators. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008; 31: 869-873

Member's Comments

No comment yet.

Related content which might interest you: Biomarkers in the management of COPD Source: Eur Respir Rev 2009; 18: 96-104 Year: 2009 Chronic obstructive lung disease and vitamin D status: Relationship with lung function, inflammatory status and exacerbations Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk index Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Estimation of a disease progression model for COPD using data from the ECLIPSE study Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013 Recommendations for epidemiological studies on COPD Source: Eur Respir J 2011; 38: 1261-1277 Year: 2011 Determinants of severity of dyspnea in COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Burden of obstructive lung disease study in Tehran: Prevalence and risk factors of COPD Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015 Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Predictive accuracy of a simple functional index in chronic obstructive pulmonary disease Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Predictor parameters for exercise intolerance in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Measuring lung inhomogeneity in early chronic lung disease Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications Year: 2016 Predictors of progression and risk of unfavorable outcome of chronic obstructive pulmonary disease Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Biological and phenomenological markers of ageing in patients with COPD and their relationship to CT emphysema scores Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 Relationship between lung cancer and chronic obstructive pulmonary disease Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Identification of oxidative stress markers and their association with inflammation in smokers and early chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016